Douglas J, Saltman S, Fredlund P, Kondo T, Catt K J
Circ Res. 1976 Jun;38(6 Suppl 2):108-12. doi: 10.1161/01.res.38.6.108.
The binding properties of the angiotensin II receptors of the adrenal cortex have been studied in isolated cells prepared by collagenase dispersion of the zona glomerulosa of the canine adrenal gland. Such cell preparations are responsive to physiological concentrations of angiotensin II, and permit correlation of binding of angiotensin II and its analogues with aldosterone production in vitro. Uptake of 125I-angiotensin II (5 X 10(-11) M) by glomerulosa cells at 37 degrees C reached a steady state at 45 minutes, with a subsequent plateau for at least 60 minutes. Angiotensin II binding was also dependent upon the hormone and cell concentrations employed during uptake studies. Bound angiotensin II was rapidly dissociated from canine adrenal cells after addition of the unlabeled octapeptide. High affinity sites with equilibrium association constant (Ka) of 3.3 X 10(9) M-1 comprised 25-33% of the receptor population and the remainder of the sites were of lower affinity, 2.5 X 10(8)M-1. Binding of angiotensin II analogues and antagonists was found to be consistent with their biological activities. The analogue most extensively evaluated was [Sar-1]angiotensin II, which exhibited enhanced binding activity when compared to angiotensin II, and had a higher equilibrium association constant by kinetic analysis and direct binding studies. Direct binding of labeled angiotensin II to the adrenal glomerulosa receptor has been correlated with a progressive response in aldosterone production. The steroidogenic response to angiotensin II was maximal when 25% of the receptor population was occupied; this fraction corresponds to the proportion of high affinity receptor sites measured by binding analysis. In addition, inhibition of angiotensin II binding to receptor sites by the competitive antagonist [Sar-1, Ala-8]angiotensin II has been correlated with inhibition of aldosterone production. These findings serve to demonstrate the biological significance of the angiotensin II binding sites of the adrenal cortex, and confirm their role as receptors which mediate the steroidogenic responses to angiotensin II.
利用胶原酶分散犬肾上腺球状带制备的分离细胞,对肾上腺皮质血管紧张素II受体的结合特性进行了研究。这种细胞制剂对血管紧张素II的生理浓度有反应,并允许在体外将血管紧张素II及其类似物的结合与醛固酮的产生相关联。在37℃下,球状带细胞对125I-血管紧张素II(5×10-11M)的摄取在45分钟时达到稳态,随后至少60分钟保持平稳。血管紧张素II的结合还取决于摄取研究中使用的激素和细胞浓度。加入未标记的八肽后,结合的血管紧张素II迅速从犬肾上腺细胞中解离。平衡缔合常数(Ka)为3.3×109M-1的高亲和力位点占受体群体的25%-33%,其余位点亲和力较低,为2.5×108M-1。发现血管紧张素II类似物和拮抗剂的结合与其生物学活性一致。评估最广泛的类似物是[Sar-1]血管紧张素II,与血管紧张素II相比,它表现出增强的结合活性,通过动力学分析和直接结合研究,其平衡缔合常数更高。标记的血管紧张素II与肾上腺球状带受体的直接结合与醛固酮产生的渐进反应相关。当25%的受体群体被占据时,对血管紧张素II的类固醇生成反应最大;这一比例对应于通过结合分析测量的高亲和力受体位点的比例。此外,竞争性拮抗剂[Sar-1,Ala-8]血管紧张素II对血管紧张素II与受体位点结合的抑制与醛固酮产生的抑制相关。这些发现证明了肾上腺皮质血管紧张素II结合位点的生物学意义,并证实了它们作为介导血管紧张素II类固醇生成反应的受体的作用。